Latest news with #JuulLabs
Daily Mail
18-07-2025
- Health
- Daily Mail
FDA reverses crucial ban on cancer-causing product as agency caves to protect profits over public safety
The FDA has authorized the sale of Juul vapes in the US, despite the company being accused of selling the cancer-linked products to young people. The agency said Thursday it will allow the sale of Juul's original e-cigarettes, along with refill cartridges in tobacco and menthol flavors. Juul, which was once a major player in the e-cigarette market before suffering a backlash after its flavored pods became popular among teens, has seen its fortunes dwindle amid lawsuits and plummeting sales. The FDA's decision will offer a new lease of life to the vape maker, which came close to filing for bankruptcy following a federal ban in 2022. However, the move comes one month after researchers at the University of California, Davis found the disposable vapes release more cancer-causing toxic metals than cigarettes. One of the disposable e-cigarettes studied released more lead levels during a day's use than nearly 20 packs of traditional cigarettes. The FDA argued that Juul submitted 'robust data' detailing how about 2million adults stopped smoking cigarettes and switched to Juul. According to the agency, this was the deciding factor in authorizing Juul products, as the benefit of helping adult smokers quit outweighed the risks to non-smokers The agency said: 'While today's actions permit these specific e-cigarette products to be legally marketed in the US to adults 21 and older, it does not mean these tobacco products are safe, nor are they FDA approved.' KC Crosthwaite, Juul's chief executive, called the move 'an important step toward making the cigarette obsolete.' He also claimed underage use of Juul products was 'down 98 percent since 2019, to one-half of one percent of youth.' While decades of research definitively show smoking cigarettes causes nine in 10 cases of lung cancer, the picture surrounding e-cigarettes is less clear. However, concerns are mounting. One February study showed vaping may be even more dangerous than smoking, as it has been linked to dementia, heart disease and organ failure. And an analysis from the University of California, Davis published last month showed disposable e-cigarettes released more toxic metals like lead and nickel in a day than a pack of 20 cigarettes. And in a case study published earlier this year, a New Jersey man died of what's thought to be the first documented case of lung cancer caused by e-cigarettes. About six percent of US adults - about 17million - vape, according to the latest CDC data. And roughly six percent of middle school students and eight percent of high school students report vaping at least once in the last 30 days. However, most young people have opted for fruit flavors, which are still not authorized in the US. Rates among young people have also drastically fallen, dropping from 27 percent of high school students in 2019 to eight percent in 2024, a 10-year low. Juul has denied allegations that it marketed its vapes to children and teenagers. It stopped selling some fruit flavors in 2019 amid backlash from parents and regulators. In 2022, the FDA announced it would ban the sale of Juul products nationwide, claiming the company had not proven keeping the vapes on shelves 'would be appropriate for the protection of the public health.' Flavored products in particular are often the target of regulations because they are easier to use as a gateway for people that do not smoke already, since one of the primary deterrents to picking up tobacco is the taste. It especially plays a role for younger smokers who use vape devices like a Juul. While they may not enjoy the taste of nicotine, it is much easier to get hooked on the fruity, tasteful, flavors. FDA commissioner Dr Marty Makary has said the agency will aggressively police the sale of unauthorized e-cigarettes from China that are often sold at convenience stores and online. Several lawmakers have opposed the authorization of Juul's products. Senator Duck Durbin, a democrat from Illinois, said in a statement that Juul 'ignited' a vaping epidemic among kids and teens and 'lied about the harms of their vapes.' He said: 'It is clear that the Trump administration does not care about our kids. 'Instead, they are giving the green light to Big Tobacco to continue lining their pockets by peddling poison.'
The Journal
18-07-2025
- Health
- The Journal
Vaping giant Juul wins key regulatory battle in US
WELL-KNOWN VAPE brand Juul has been approved for sale in the US three years after being temporarily banned by US health authorities during the Biden administration in 2022. The US Food and Drug Administration (FDA) had originally banned the vapes as Juul did not prove its products would be 'appropriate for the protection of the public health', although this measure was suspended after two weeks to conduct a scientific review. On Thursday, Juul Labs said that the FDA had officially authorised it to market its vaping system and refill capsules. The decision means Juul can continue to sell products that have been on the US market. The well-known e-cigarette brand was available on the Irish market for only two years after being launched in 2019. Juul Labs exited several European markets at the end of 2020. Its products were authorised for sale in the US as the benefits for smoking cessation were 'sufficient to outweigh the risks of the product,' including to anyone not using tobacco products. Advertisement Juul markets its products as providing a public health benefit because they can shift smokers away from cigarettes closely linked to deadly illnesses. But the company has been criticised for its marketing practices, agreeing to pay $438.5m (€375.93m) in a 2022 settlement with 34 US states to resolve accusations of marketing to underage smokers. Juul won the new marketing granting orders (MGO) after submitting more than 110 scientific studies to the agency, it said in a statement. 'Following rigorous evaluation of the data, FDA decided that an MGO for the Juul System was 'appropriate for the protection of public health' – the standard required by statute for authorisation,' Juul said. However, a spokesperson for the US Department of Health and Human Services said its decision 'does not mean these tobacco products are safe, nor are they 'FDA approved''. The Department also indicated it will continue to monitor Juul's compliance with youth marketing restrictions.
eNCA
18-07-2025
- Business
- eNCA
US authorises Juul to market vaping products
WASHINGTON - Juul Labs said that the US Food and Drug Administration had officially authorised the e-cigarette maker to market its vaping system and refill capsules in the United States. Juul won the new marketing granting orders (MGO) after submitting more than 110 scientific studies to the agency, the company said in a statement. The decision means Juul can continue to sell products that have been on the US market but in regulatory limbo following earlier actions by the FDA. "Following rigorous evaluation of the data, FDA decided that an MGO for the Juul System was 'appropriate for the protection of public health' –- the standard required by statute for authorisation," Juul said. Juul has argued that its vaping products provide a public health benefit by shifting smokers away from combustible tobacco products closely linked to deadly illnesses. But the company has been criticised for its marketing practices, agreeing to pay $438.5-million in a 2022 settlement with 34 US states to resolve accusations of marketing to underage smokers. The FDA's move allows Juul to sell five products in all: the Juul device and capsules for the "Virginia Tobacco" and menthol flavour, each in versions with three or five percent nicotine concentration, said a spokesperson for the US Department of Health and Human Services. The products needed to meet the standard set under a 2009 smoking prevention law showing that the benefits of switching to a potentially less harmful product is "sufficient to outweigh the risks of the product," including to anyone not using tobacco products, the spokesperson said. The applicant submitted data "demonstrating high rates of adults completely switching from cigarettes to either the tobacco- or menthol-flavoured Juul products." But the agency's determination "does not mean these tobacco products are safe, nor are they 'FDA approved,'" said the spokesperson, who added that the agency will continue to monitor Juul's compliance with youth marketing restrictions. Juul survived a difficult stretch after the FDA ordered it to halt sales in June 2022 because of health questions, although the decision was administratively suspended by the same agency shortly thereafter. In June 2024, the FDA formally rescinded its June 2022 order, shifting the matter back into "pending" status while a substantive review continued. The FDA's action on Thursday "confirms that these products are now authorised to remain on the market," said a Juul spokesman.
The Independent
17-07-2025
- Health
- The Independent
FDA authorizes Juul to continue selling e-cigarettes
The Food and Drug Administration (FDA) has ruled that vaping brand Juul Labs can continue to sell its e-cigarettes and refill cartridges in the US. The FDA's decision was based on Juul's studies, which demonstrated that its e-cigarettes are less harmful for adult smokers who switch from traditional cigarettes. This ruling provides a new lease of life for Juul, which has faced years of intense regulatory scrutiny, numerous lawsuits, and significant financial difficulties due to concerns over teen vaping. Juul will be one of only two companies permitted to sell menthol-flavored vapes in the US following this decision. The ruling has drawn criticism from parents and anti-tobacco groups, who argue that Juul was responsible for the surge in youth vaping.
Int'l Business Times
17-07-2025
- Business
- Int'l Business Times
US Authorizes Juul To Market Vaping Products
Juul Labs said Thursday that the US Food and Drug Administration had officially authorized the e-cigarette maker to market its vaping system and refill capsules in the United States. Juul won the new marketing granting orders (MGO) after submitting more than 110 scientific studies to the agency, the company said in a statement. The decision means Juul can continue to sell products that have been on the US market but in regulatory limbo following earlier actions by the FDA. "Following rigorous evaluation of the data, FDA decided that an MGO for the Juul System was 'appropriate for the protection of public health' -- the standard required by statute for authorization," Juul said. Juul has argued that its vaping products provide a public health benefit by shifting smokers away from combustible tobacco products closely linked to deadly illnesses. But the company has been criticized for its marketing practices, agreeing to pay $438.5 million in a 2022 settlement with 34 US states to resolve accusations of marketing to underage smokers. The FDA's move allows Juul to sell five products in all: the Juul device and capsules for the "Virginia Tobacco" and menthol flavor, each in versions with three or five percent nicotine concentration, said a spokesperson for the US Department of Health and Human Services. The products needed to meet the standard set under a 2009 smoking prevention law showing that the benefits of switching to a potentially less harmful product is "sufficient to outweigh the risks of the product," including to anyone not using tobacco products, the spokesperson said. The applicant submitted data "demonstrating high rates of adults completely switching from cigarettes to either the tobacco- or menthol-flavored Juul products." But the agency's determination "does not mean these tobacco products are safe, nor are they 'FDA approved,'" said the spokesperson, who added that the agency will continue to monitor Juul's compliance with youth marketing restrictions. Juul survived a difficult stretch after the FDA ordered it to halt sales in June 2022 because of health questions, although the decision was adminsistratively suspended by the same agency shortly thereafter. In June 2024, the FDA formally rescinded its June 2022 order, shifting the matter back into "pending" status while a substantive review continued. The FDA's action on Thursday "confirms that these products are now authorized to remain on the market," said a Juul spokesman.
